Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Russmann

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Pharmacogenomics|January 17, 2024
Antiplatelet therapy guided by <i>CYP2C19</i> point-of-care pharmacogenetics plus multidimensional treatment decisionsVictor Voicu, Nicolas Diehm, Igal Moarof, et al.
Expert Opinion on Drug Safety|February 21, 2013
Medication wrong route administration: a poisons center-based studyAlexandra Bloch-Teitelbaum, Saskia Lüde, Christine Rauber-Lüthy, et al.
Journal of Clinical Medicine|August 12, 2023
Identification of Medication Prescription Errors and Factors of Clinical Relevance in 314 Hospitalized Patients for Improved Multidimensional Clinical Decision Support AlgorithmsStefan Russmann, Fabiana Martinelli, Franziska Jakobs, et al.
Pharmacoepidemiology and Drug Safety|July 21, 2011
Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)Markus Guzek, Olesya I Zorina, Alexander Semmler, et al.
Journal of Clinical Medicine|April 26, 2025
Cardiotoxicity Associated with Venlafaxine-Defining Features in a Series of Five Cases and a Call for Proactive MonitoringBujana Batusha Sopi, Keiko Yonekawa, Stefan Russmann, et al.
Journal of Clinical Medicine|August 7, 2021
Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 PatientsDavid F Niedrig, Ali Rahmany, Kai Heib, et al.
European Journal of Clinical Pharmacology|November 26, 2020
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practiceStefan Russmann, Ali Rahmany, David Niedrig, et al.
Pharmacoepidemiology and Drug Safety|April 21, 2012
Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatientsOlesya I Zorina, Patrick Haueis, Alexander Semmler, et al.
Swiss Medical Weekly|July 11, 2012
Drug-related problems and factors influencing acceptance of clinical pharmacologists` alerts in a large cohort of neurology inpatientsAnne B Taegtmeyer, Ivanka Curkovic, Natascia Corti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2012
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional studyIvana Pavik, Philippe Jaeger, Lena Ebner, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Pharmacogenomics|January 17, 2024
Antiplatelet therapy guided by <i>CYP2C19</i> point-of-care pharmacogenetics plus multidimensional treatment decisionsVictor Voicu, Nicolas Diehm, Igal Moarof, et al.
Expert Opinion on Drug Safety|February 21, 2013
Medication wrong route administration: a poisons center-based studyAlexandra Bloch-Teitelbaum, Saskia Lüde, Christine Rauber-Lüthy, et al.
Journal of Clinical Medicine|August 12, 2023
Identification of Medication Prescription Errors and Factors of Clinical Relevance in 314 Hospitalized Patients for Improved Multidimensional Clinical Decision Support AlgorithmsStefan Russmann, Fabiana Martinelli, Franziska Jakobs, et al.
Pharmacoepidemiology and Drug Safety|July 21, 2011
Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)Markus Guzek, Olesya I Zorina, Alexander Semmler, et al.
Journal of Clinical Medicine|April 26, 2025
Cardiotoxicity Associated with Venlafaxine-Defining Features in a Series of Five Cases and a Call for Proactive MonitoringBujana Batusha Sopi, Keiko Yonekawa, Stefan Russmann, et al.
Journal of Clinical Medicine|August 7, 2021
Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 PatientsDavid F Niedrig, Ali Rahmany, Kai Heib, et al.
European Journal of Clinical Pharmacology|November 26, 2020
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practiceStefan Russmann, Ali Rahmany, David Niedrig, et al.
Pharmacoepidemiology and Drug Safety|April 21, 2012
Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatientsOlesya I Zorina, Patrick Haueis, Alexander Semmler, et al.
Swiss Medical Weekly|July 11, 2012
Drug-related problems and factors influencing acceptance of clinical pharmacologists` alerts in a large cohort of neurology inpatientsAnne B Taegtmeyer, Ivanka Curkovic, Natascia Corti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2012
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional studyIvana Pavik, Philippe Jaeger, Lena Ebner, et al.
Pageof 6